Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through the Optimization of the Osteoblastic Niche
Open Access
- 14 May 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5) , e0125995
Abstract
We previously reported a new approach for culturing difficult-to-preserve primary patient-derived multiple myeloma cells (MMC) using an osteoblast (OSB)-derived 3D tissue scaffold constructed in a perfused microfluidic environment and a culture medium supplemented with patient plasma. In the current study, we used this biomimetic model to show, for the first time, that the long-term survival of OSB is the most critical factor in maintaining the ex vivo viability and proliferative capacity of MMC. We found that the adhesion and retention of MMC to the tissue scaffold was meditated by osteoblastic N-cadherin, as one of potential mechanisms that regulate MMC-OSB interactions. However, in the presence of MMC and patient plasma, the viability and osteogenic activity of OSB became gradually compromised, and consequently MMC could not remain viable over 3 weeks. We demonstrated that the long-term survival of both OSB and MMC could be enhanced by: (1) optimizing perfusion flow rate and patient-derived plasma composition in the culture medium and (2) replenishing OSB during culture as a practical means of prolonging MMC’s viability beyond several weeks. These findings were obtained using a high-throughput well plate-based perfusion device from the perspective of optimizing the ex vivo preservation of patient-derived MM biospecimens for downstream use in biological studies and chemosensitivity analyses.Keywords
This publication has 44 references indexed in Scilit:
- Characterization of a Novel Mouse Model of Multiple Myeloma and Its Use in Preclinical Therapeutic AssessmentPLOS ONE, 2013
- Mechanical Strain Regulates Osteoblast Proliferation through Integrin-Mediated ERK ActivationPLOS ONE, 2012
- N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiationHaematologica, 2011
- Treatment of multiple myelomaNature Reviews Clinical Oncology, 2011
- Shear flow-induced formation of tubular cell protrusions in multiple myeloma cellsJournal of Cellular Physiology, 2011
- A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cellsLeukemia, 2011
- Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblastsBritish Journal of Cancer, 2011
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistanceNature Medicine, 2010
- Myeloma cells inhibit osteogenic differentiation of mesenchymal stem cells and kill osteoblasts via TRAIL-induced apoptosisArchives of Medical Science, 2010
- The Mechanical Environment of Bone Marrow: A ReviewAnnals of Biomedical Engineering, 2008